National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1133722

History of Changes from the VAERS Wayback Machine

First Appeared on 3/26/2021

VAERS ID: 1133722
VAERS Form:2
Age:56.0
Sex:Male
Location:Maryland
Vaccinated:2021-03-13
Onset:2021-03-19
Submitted:0000-00-00
Entered:2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private      Purchased by: ??
Symptoms: Areflexia, CSF glucose normal, CSF protein increased, Guillain-Barre syndrome, Hypoaesthesia, Muscular weakness, CSF white blood cell count increased, CSF red blood cell count

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: NAC, Rehmannia 6 supplements and Maca root supplements.
Current Illness: none known
Preexisting Conditions: none known
Allergies: none known
Diagnostic Lab Data: Lumbar puncture (3/23): CSF labs: 3/23/2021: Glucose, CSF 60 mg/dL; Protein,Total, CSF 74.0 mg/dL; Red Blood Count, CSF 21,000 /cu mm; Red Blood Count, CSF 1,000 /cu mm; White Blood Count, CSF 39 /cu mm; White Blood Count, CSF 6 /cu mm
CDC 'Split Type':

Write-up: Beginning on 3/19 he developed a progressive ascending numbness first in his toes, then progressing to include bilateral legs up to knees and bilateral arms up to mid forearm. He also had mild leg weakness bilaterally. He has absent reflexes. His lumbar puncture showed albuminocytologic dissociation. He was diagnosed with Guillan-Barre syndrome and is being treated with IVIG.


Changed on 5/7/2021

VAERS ID: 1133722 Before After
VAERS Form:2
Age:56.0
Sex:Male
Location:Maryland
Vaccinated:2021-03-13
Onset:2021-03-19
Submitted:0000-00-00
Entered:2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private      Purchased by: ??
Symptoms: Areflexia, CSF glucose normal, CSF protein increased, Guillain-Barre syndrome, Hypoaesthesia, Muscular weakness, CSF white blood cell count increased, CSF red blood cell count

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: NAC, Rehmannia 6 supplements and Maca root supplements.
Current Illness: none known
Preexisting Conditions: none known
Allergies: none known known
Diagnostic Lab Data: Lumbar puncture (3/23): CSF labs: 3/23/2021: Glucose, CSF 60 mg/dL; Protein,Total, CSF 74.0 mg/dL; Red Blood Count, CSF 21,000 /cu mm; Red Blood Count, CSF 1,000 /cu mm; White Blood Count, CSF 39 /cu mm; White Blood Count, CSF 6 /cu mm
CDC 'Split Type':

Write-up: Beginning on 3/19 he developed a progressive ascending numbness first in his toes, then progressing to include bilateral legs up to knees and bilateral arms up to mid forearm. He also had mild leg weakness bilaterally. He has absent reflexes. His lumbar puncture showed albuminocytologic dissociation. He was diagnosed with Guillan-Barre syndrome and is being treated with IVIG.


Changed on 5/14/2021

VAERS ID: 1133722 Before After
VAERS Form:2
Age:56.0
Sex:Male
Location:Maryland
Vaccinated:2021-03-13
Onset:2021-03-19
Submitted:0000-00-00
Entered:2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private      Purchased by: ??
Symptoms: Areflexia, CSF glucose normal, CSF protein increased, Guillain-Barre syndrome, Hypoaesthesia, Muscular weakness, CSF white blood cell count increased, CSF red blood cell count

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: NAC, Rehmannia 6 supplements and Maca root supplements.
Current Illness: none known
Preexisting Conditions: none known
Allergies: none known known
Diagnostic Lab Data: Lumbar puncture (3/23): CSF labs: 3/23/2021: Glucose, CSF 60 mg/dL; Protein,Total, CSF 74.0 mg/dL; Red Blood Count, CSF 21,000 /cu mm; Red Blood Count, CSF 1,000 /cu mm; White Blood Count, CSF 39 /cu mm; White Blood Count, CSF 6 /cu mm
CDC 'Split Type':

Write-up: Beginning on 3/19 he developed a progressive ascending numbness first in his toes, then progressing to include bilateral legs up to knees and bilateral arms up to mid forearm. He also had mild leg weakness bilaterally. He has absent reflexes. His lumbar puncture showed albuminocytologic dissociation. He was diagnosed with Guillan-Barre syndrome and is being treated with IVIG.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1133722&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166